Published in Ecancermedicalscience on April 09, 2015
miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol (2015) 0.83
The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.79
Racial Disparities in Colorectal Carcinoma Incidence, Severity and Survival Times Over 10 Years: A Retrospective Single Center Study. J Clin Med Res (2016) 0.78
Recent insights into nanotechnology development for detection and treatment of colorectal cancer. Int J Nanomedicine (2016) 0.77
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies. Drug Des Devel Ther (2017) 0.75
Circular RNAs in colorectal cancer: Possible roles in regulation of cancer cells. World J Gastrointest Oncol (2017) 0.75
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun Signal (2017) 0.75
Diagnostic Accuracy of Five Different Fecal Markers for the Detection of Precancerous and Cancerous Lesions of the Colorectum. Mediators Inflamm (2016) 0.75
Tumor suppressor genes in familial adenomatous polyposis. Gastroenterol Hepatol Bed Bench (2017) 0.75
Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. J Cancer Res Clin Oncol (2015) 0.75
Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis. Oncotarget (2016) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Surfing the p53 network. Nature (2000) 35.36
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Identification and characterization of the familial adenomatous polyposis coli gene. Cell (1991) 14.46
Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature (2012) 9.39
RAS oncogenes: the first 30 years. Nat Rev Cancer (2003) 8.61
Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res (2006) 8.26
Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta (2003) 7.85
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol (2010) 7.73
Microsatellite instability in colorectal cancer. Gastroenterology (2010) 7.39
Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (1997) 7.31
Association of the APC tumor suppressor protein with catenins. Science (1993) 7.17
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet (2002) 7.00
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43
Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res (2007) 5.62
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol (1991) 5.61
Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) (1999) 4.85
Molecular signals of epigenetic states. Science (2010) 4.81
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov (2012) 4.72
Colorectal cancer: molecules and populations. J Natl Cancer Inst (1999) 4.39
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science (2010) 4.37
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol (2010) 4.22
Mechanisms and functions of DNA mismatch repair. Cell Res (2008) 4.16
The ABC of APC. Hum Mol Genet (2001) 4.16
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
APC binds to the novel protein EB1. Cancer Res (1995) 3.98
Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol (2003) 3.67
New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev (2001) 3.63
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta (1997) 3.31
The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol (2003) 3.06
Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist (2003) 3.04
Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity (2007) 2.71
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer (2011) 2.68
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev (2004) 2.52
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin Cancer Res (2003) 2.48
Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci (2007) 2.41
Epigenetic changes in colorectal cancer. Cancer Metastasis Rev (2004) 2.35
Muir-Torre syndrome. Lancet Oncol (2005) 2.27
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis (2007) 2.27
The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res (2010) 2.23
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. Cancer Res (2011) 2.22
Familial adenomatous polyposis. Orphanet J Rare Dis (2009) 2.21
Ras history: The saga continues. Small GTPases (2010) 2.18
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum (1960) 2.06
Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci U S A (1993) 2.05
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation (1996) 2.04
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
Cancer stem cell: target for anti-cancer therapy. FASEB J (2007) 1.92
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin Cancer Res (2012) 1.92
The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med (2003) 1.84
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer. Pathol Res Pract (2009) 1.80
Selective targeting of cancer stem cells: a new concept in cancer therapeutics. BioDrugs (2007) 1.76
Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene (2002) 1.75
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol (2003) 1.74
An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res (2007) 1.73
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet (2004) 1.66
HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer (2004) 1.60
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology (2014) 1.57
WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology (2001) 1.56
Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest (2007) 1.51
Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. J Cell Sci (2003) 1.51
Biology of colorectal cancer. Cancer J (2010) 1.50
Colon cancer: a civilization disorder. Dig Dis (2011) 1.49
BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study. Mol Cancer (2011) 1.47
Cancer cells exhibit a mutator phenotype. Adv Cancer Res (1998) 1.46
Microsatellite instability in colorectal cancer. Br J Surg (2006) 1.46
A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol (2012) 1.44
Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol (2004) 1.40
Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev (2006) 1.36
Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer (1993) 1.36
Clinical relevance of KRAS in human cancers. J Biomed Biotechnol (2010) 1.34
Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res (1999) 1.33
Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol (2003) 1.32
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treat Rev (2011) 1.30
Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A (2011) 1.29
Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer (2001) 1.27
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol (2002) 1.27
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. Int J Cancer (2013) 1.26
Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer. Oncol Rep (2009) 1.24
Clinical significance of small colorectal polyps. Dis Colon Rectum (2004) 1.23
Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res (2005) 1.20
Whole-genome methylation analysis of benign and malignant colorectal tumours. J Pathol (2013) 1.20
Colorectal carcinogenesis--update and perspectives. World J Gastroenterol (2014) 1.19
Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer. Mol Cancer Ther (2010) 1.19
Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev (2010) 1.19
The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease. Mol Med Today (2000) 1.18
Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16
Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology (2002) 1.15
Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation. Fam Cancer (2008) 1.09
Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics (2012) 1.08